Principal ScientistPfizer Inc.Cambridge, Massachusetts, United States
PB0187 - Impact of One-Stage Clotting Assay Reagents on Factor XIa Levels and Clotting Time with High Activity Factor IX (R338L) Variant
Sunday, June 25, 202318:30 – 19:30 ET